Pricing Log in Create free account

OKYO Pharma Limited Sponsored ADR (OKYO) vs PDS Biotechnology Corporation (PDSB)

OKYO Pharma Limited Sponsored ADR and PDS Biotechnology Corporation are both Biotechnology companies. OKYO Pharma Limited Sponsored ADR and PDS Biotechnology Corporation are of similar size ($75.1M and $72.8M). Across the 8 metrics below, OKYO Pharma Limited Sponsored ADR leads on 5 and PDS Biotechnology Corporation on 3.

Valuation

Metric OKYO PDSB Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 86.44 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield 0.00% (57.14%) (33.15%)
Free cash flow yield (0.89%) (26.53%) (25.50%)

Profitability

Metric OKYO PDSB Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin — 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (543.97%) (56.36%)
Return on assets 0.00% (136.65%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric OKYO PDSB Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) (101.34%) 28.16% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric OKYO PDSB Biotechnology median
Debt to equity 0.00 (1.21) 0.00
Current ratio 2.43 0.57 4.72
Net debt to EBITDA 2.42 0.50 0.96

Dividend

Metric OKYO PDSB Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric OKYO PDSB Biotechnology median
Market cap 75.05m 72.76m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack